On­colyt­ic play­er abrupt­ly ter­mi­nates CMO, on­ly a year in, and elim­i­nates the job

A lit­tle more than a year af­ter Replimune CEO Philip Ast­ley-Sparke re­cruit­ed An­drea Pirzkall from BeiGene to run the de­vel­op­ment pro­grams for its on­colyt­ic im­muno …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER